Tesamorelin Clinics in Pennsylvania
4 physician-supervised clinics prescribing Tesamorelin for Pennsylvania residents — 2 in-state locations plus 2 telehealth providers. Compare consultation fees, treatment areas, and access before you enquire.
In-state clinics (2)
Physician-supervised · Board certified
Telehealth providers serving Pennsylvania (2)
Physician-supervised · Board certified
Physician-supervised · Board certified
Tesamorelin clinics in other states
Tesamorelin in Pennsylvania
Peptide Finder currently lists 4 physician-supervised clinics prescribing Tesamorelin for Pennsylvania residents - 2 with an in-state locations and 2 licensed telehealth providers serving the state. Telehealth availability in Pennsylvaniadepends on each clinic's licensure and operations, so confirm coverage when you enquire.
Tesamorelin is an FDA-approved synthetic GHRH analogue - the only active GH-releasing peptide with full US marketing authorization. It was approved as Egrifta in 2010 for the reduction of excess abdominal fat (lipodystrophy) in HIV-positive patients on antiretroviral therapy.
Informational only - not medical advice. Whether Tesamorelin is appropriate, legal, or available to you in Pennsylvania is decided by a licensed US prescriber after an individual assessment.
Read the full Tesamorelin guide →